Rel-Licogliflozin
Rel-Licogliflozin is a relative configuration of Licogliflozin. Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor[1].
Product Specifications
CAS Number
2730989-98-5
Product Name Alternative
Rel-LIK066
UNSPSC
12352005
Target
SGLT
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology
Smiles
O[C@H]1[C@H](C2=CC(CC3=CC=C4C(OCCO4)=C3)=C(CC)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O
Molecular Formula
C23H28O7
Molecular Weight
416.46
References & Citations
[1]Monica A. Konerman, et al. Overview of Clinical Treatment Trials for NASH.Curr Hepatol Rep. 2017 Dec;16 (4) : 366-373.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SGLT1; SGLT2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-90681AF594 0.1 mL
Rabbit Monoclonal CD83 Antibody (005) [Alexa Fluor 594]
Sign In for Pricing
View Details 
LV781586 1.0 µg DNA
RPLP0P10 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details